1. Home
  2. INSG vs ATOS Comparison

INSG vs ATOS Comparison

Compare INSG & ATOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INSG
  • ATOS
  • Stock Information
  • Founded
  • INSG 1996
  • ATOS 2009
  • Country
  • INSG United States
  • ATOS United States
  • Employees
  • INSG N/A
  • ATOS N/A
  • Industry
  • INSG Telecommunications Equipment
  • ATOS Biotechnology: Pharmaceutical Preparations
  • Sector
  • INSG Telecommunications
  • ATOS Health Care
  • Exchange
  • INSG Nasdaq
  • ATOS Nasdaq
  • Market Cap
  • INSG 111.5M
  • ATOS 96.8M
  • IPO Year
  • INSG 2000
  • ATOS 2012
  • Fundamental
  • Price
  • INSG $7.29
  • ATOS $0.62
  • Analyst Decision
  • INSG Buy
  • ATOS Strong Buy
  • Analyst Count
  • INSG 3
  • ATOS 3
  • Target Price
  • INSG $13.00
  • ATOS $7.00
  • AVG Volume (30 Days)
  • INSG 104.6K
  • ATOS 699.0K
  • Earning Date
  • INSG 05-08-2025
  • ATOS 05-12-2025
  • Dividend Yield
  • INSG N/A
  • ATOS N/A
  • EPS Growth
  • INSG N/A
  • ATOS N/A
  • EPS
  • INSG 0.10
  • ATOS N/A
  • Revenue
  • INSG $191,244,000.00
  • ATOS N/A
  • Revenue This Year
  • INSG $2.53
  • ATOS N/A
  • Revenue Next Year
  • INSG $11.55
  • ATOS N/A
  • P/E Ratio
  • INSG $83.96
  • ATOS N/A
  • Revenue Growth
  • INSG 14.32
  • ATOS N/A
  • 52 Week Low
  • INSG $2.22
  • ATOS $0.55
  • 52 Week High
  • INSG $20.67
  • ATOS $1.81
  • Technical
  • Relative Strength Index (RSI)
  • INSG 36.13
  • ATOS 42.51
  • Support Level
  • INSG $7.08
  • ATOS $0.56
  • Resistance Level
  • INSG $7.65
  • ATOS $0.67
  • Average True Range (ATR)
  • INSG 0.59
  • ATOS 0.06
  • MACD
  • INSG 0.06
  • ATOS 0.00
  • Stochastic Oscillator
  • INSG 43.93
  • ATOS 43.75

About INSG Inseego Corp.

Inseego Corp is into the design and development of fixed and mobile wireless solutions (4G and 5G NR), Industrial Internet of Things and cloud solutions for enterprises, service providers, small and medium-sized businesses, governments, and consumers around the globe. Its products and services include intelligent mobile hotspots, wireless routers for IoT applications, USB modems, integrated telematics and mobile tracking devices, which are supported by applications software and cloud services designed to enable customers to easily analyze data insights and configure and manage their hardware. It generates maximum revenue from United States and Canada. The company also has a presence in Australia and Europe (including United Kingdom).

About ATOS Atossa Therapeutics Inc.

Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.

Share on Social Networks: